Amalgam
Wilmington, US · Founded 2016 · Delaware corporation · 51 employees on LinkedIn · 3 known investors
Amalgam builds a modular, AI-powered Software as a Medical Device (SaMD) platform and EHR-integrated solutions for life sciences companies, health plans, and providers to support clinical decisions, patient engagement, and digital therapeutics. It also acts as Manufacturer of Record for regulated software, holding regulatory clearance across four continents.
Founders & leadership
Amalgam was founded in 2016 by RYAN A. SYSKO and Ryan Sysko.
Board
Investors · 3
Reported raises · per SEC filings
Form D private placements$27.3M disclosed across 5 rounds · 2016–2025
▶$7.9MraisedAug 2025 · 28 investors · Other Health CareRule 506(b)
- SONNY VUDirector
- JEFFREY P. COURTNEYDirector
- RYAN A. SYSKOExecutive Officer, Director
- Offering amount
- $7.9M
- Amount sold
- $7.9M
- Sales commissions
- $616.3K
- Placement agents
- ERG SECURITIES (US) LLC
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17.4MraisedJan 2023 · 62 investors · Other Health CareRule 506(b)
- Sonny VuDirector
- Ryan SyskoExecutive Officer, Director
- Jeffrey CourtneyDirector
- Offering amount
- $45M
- Amount sold
- $17.4M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$650KraisedOct 2019 · 5 investors · Other Health CareRule 506(b)
- Ryan A SyskoExecutive Officer, Director
- Sarwar IslamDirector
- Offering amount
- $750K
- Amount sold
- $650K
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$1.2MraisedMay 2019 · 27 investors · Other Health CareRule 506(b)
- Sarwar IslamDirector
- Ryan A SyskoExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.2M
- Finders' fees
- $9.4K
- Placement agents
- Steven Sarigianis
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$215KraisedMar 2016 · 7 investors · Other Health CareRule 506(b)
- Ryan Adam SyskoExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $215K
- Minimum investment
- $25K
- Proceeds to insiders
- $105K
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapCompanies competing with Amalgam for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Amalgam do?
- Amalgam builds a modular, AI-powered Software as a Medical Device (SaMD) platform and EHR-integrated solutions for life sciences companies, health plans, and providers to support clinical decisions, patient engagement, and digital therapeutics. It also acts as Manufacturer of Record for regulated software, holding regulatory clearance across four continents.
- Who founded Amalgam?
- Amalgam was founded by RYAN A. SYSKO, Ryan Sysko in 2016.
- Who are Amalgam's investors?
- Amalgam's investors include Catalio Capital Management, LP, CVS Health Ventures, Supermorpheus.
- How much funding has Amalgam raised?
- Amalgam has disclosed $27.3M raised across 5 rounds.
- Where is Amalgam headquartered?
- Amalgam is headquartered in Wilmington, US.




